Venture Capital Had a Record First Half in 2026
Record Funding Reached Historic Levels
Venture Capital Just Had Its Biggest Half-Year Ever. Here's What It Actually Means For Most Companies.
That's what North American startups raised in the first six months of 2026, the biggest half-year in venture capital history. If you run a growing company and just skimmed past that number, assuming it has nothing to do with you, you're half right. You're not raising $65 billion. Almost nobody is. But the story behind that number is really about how capital is flowing right now, and why this is a very good time to raise capital the old-fashioned way. By the end of this, you'll know exactly where you fit into it.
If that sounds like something I said about the first quarter, too, that's because it's the same pattern repeating. Q1 was driven by OpenAI, which raised the largest venture round in history. Q2 came in lower, but it was still the second-biggest quarter on record, and a single Anthropic financing accounted for roughly half of everything raised in the period.
Add it up, and U.S. and Canadian startups pulled in $392 billion in the first six months of 2026. Q2 alone was $137.2 billion. Both numbers dwarf anything from prior years, aside from the quarter that came right before.
The Real Story Behind the Numbers
Here's the part I want you to notice: this wasn't more companies getting funded. Deal count stayed well below prior highs in both quarters. A small number of enormous rounds did all the heavy lifting. Capital concentrated hard at the late stage, though early-stage investing did tick up in Q2, again mostly on the back of AI.
The exit side of the ledger was just as extreme. SpaceX delivered the largest IPO ever, then followed it with the largest startup acquisition ever, buying Cursor. A handful of other sizable IPOs and acquisitions rounded out the quarter.
What You'll Learn From These Trends
Below, I'll walk through the numbers by stage, the AI concentration, and the big IPOs and M&A deals. Then I'll get to the part that matters most if you're not raising billions: what this capital environment means for you.
Where Venture Capital Was Invested
Late-Stage Companies Captured the Largest Share
This is where the bulk of the money went, so we'll start here.
Late-stage and growth funding came in around $101 billion for the quarter. That's the second-highest total in five quarters and the second-highest of all time.
Anthropic was the standout, raising $65 billion at a $965 billion post-money valuation. $50 billion of that came in a May round led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital, with Amazon and Google chipping in $5 billion and $10 billion, respectively, through corporate-led rounds. Anthropic then filed confidentially for an IPO in June.
Anduril Industries also had a strong quarter, closing a $5 billion Series H led by Thrive Capital and Andreessen Horowitz.
Early-Stage Funding Rebounded
Early-stage funding hit its highest level in more than three years in Q2, suggesting megadeals aren't just a late-stage story anymore.
North American early-stage funding totaled just over $31 billion, nearly double what it was a year earlier and up about 15% from Q1. Deal count, on the other hand, hit its lowest point in five quarters. Fewer companies got funded, but the checks got much bigger.
One deal alone, a $12 billion financing for physical-AI startup Prometheus (co-founded by Jeff Bezos), made up more than 40% of the quarter's early-stage total. The next tier down was still substantial by early-stage standards: Hark raised $700 million for its "personalized intelligence" work, Flourish raised $500 million to build an AI system modeled on the human brain, and Generalist AI closed $400 million for AI robotics.
Seed Funding Lost Momentum
Seed was the exception to the trend, actually declining.
Seed and angel funding totaled around $4.9 billion for the quarter, down 15% from Q1 and 27% from a year earlier. Round counts dropped too, though that number tends to creep up over time as smaller seed deals get reported weeks or months late.
Even here, a few outsized rounds did most of the work. Mirendil, a foundational AI research startup, raised $200 million, and at least five companies closed seed or angel rounds of $100 million or more during the quarter.
AI Continued to Dominate Investment
About 80% of venture investment in Q2, across all stages, went to AI-focused startups. That's nearly triple what it was a year ago, though still below Q1's number, which benefited from OpenAI's record-setting $122 billion round.
Most of that AI total, unsurprisingly, traces back to the three rounds already mentioned: Anthropic, Prometheus and Anduril.
Record-Breaking Exits
Major Exits Shaped the Quarter
Investors didn't just write checks this quarter. They also cashed some in.
The Biggest IPOs of Q2
SpaceX went public in June and raised $75 billion in its IPO, the largest in history. Its market cap now sits at around $2.1 trillion, making it the sixth-most valuable public company in America. Nobody else came close, but the quarter still delivered a solid run of venture-backed debuts, led by AI chip designer Cerebras Systems, which raised $5.6 billion in its May IPO.
Quantum computing company Quantinuum followed with its own big Nasdaq debut in June. X-energy, a developer of modular nuclear reactors, also went public during the quarter. The largest venture-backed IPOs of the quarter:
| Organization Name | Description | Money Raised at IPO (USD) | Valuation at IPO (USD) |
|---|---|---|---|
| SpaceX | Rockets, satellite networks, and AI infrastructure. | $74,999,999,925 | $1,770,000,000,000 |
| Cerebras Systems | AI computing hardware and infrastructure. | $5,550,000,000 | $56,400,000,000 |
| Quantinuum | Quantum computing across chemistry, cybersecurity, and finance. | $1,680,000,000 | $15,600,000,000 |
| X-energy | Small modular nuclear reactors and nuclear fuels. | $1,017,857,157 | $9,122,650,000 |
| Fervo Energy | Carbon-free energy from geothermal systems. | $1,890,000,000 | $7,656,120,000 |
| Parabilis Medicines | Biopharmaceutical medicine development. | $770,500,000 | $2,400,000,000 |
| Kailera Therapeutics | Injectable and oral therapies for weight management. | $625,000,000 | $1,978,880,000 |
| Liftoff | Mobile app marketing and monetization. | $437,000,000 | $3,829,040,000 |
| HawkEye 360 | Satellite-based RF signal detection. | $416,000,000 | $2,420,060,000 |
| Kardigan | AI-driven personalized medicine for cardiovascular disease. | $400,000,000 | $1,429,430,000 |
| Aevex Aerospace | Airborne intelligence solutions. | $320,000,000 | $2,236,520,000 |
| Lightelligence | A technology company built around light-based innovation. | $322,516,077 | $2,150,107,109 |
| Alamar Biosciences | Precision proteomics for early disease detection. | $191,250,000 | $1,135,020,000 |
Largest Startup Acquisitions
The quarter's biggest acquisition was also the largest startup acquisition ever recorded: SpaceX bought Cursor's parent company, Anysphere, for $60 billion. SpaceX first announced an option to buy back the company in April and closed the deal after its own IPO.
In biotech, Eli Lilly's acquisition of gene therapy developer Kelonia Therapeutics, worth up to $7 billion, led the way. Qualcomm's purchase of AI chip startup Modular and Salesforce's acquisition of AI customer-experience company Fin rounded out the top deals, alongside Autodesk's purchase of MaintainX. Here are the largest transactions of the quarter:
Largest Q2 2026 Startup Acquisitions
| Transaction Name | Acquiree Name | Acquirer Name | Price |
|---|---|---|---|
| Anysphere (Cursor) acquired by SpaceX | Anysphere (Cursor) | SpaceX | $60,000,000,000 |
| Kelonia Therapeutics acquired by Eli Lilly | Kelonia Therapeutics | Eli Lilly | $7,000,000,000 |
| Modular acquired by Qualcomm | Modular | Qualcomm | $3,900,000,000 |
| Fin acquired by Salesforce | Fin | Salesforce | $3,600,000,000 |
| MaintainX acquired by Autodesk | MaintainX | Autodesk | $3,600,000,000 |
What These Trends Mean for the Venture Market
An Unprecedented Capital Environment
If you're looking for a comparable period in startup history to make sense of all this, you won't find one. We've never seen funding rounds this large, a venture-backed debut valued this high, or an acquisition anywhere near the size of the Cursor deal.
Looking ahead, the companies and investors driving these numbers seem to expect current conditions to persist. Anthropic and OpenAI have both signaled they intend to go public at valuations of $1 trillion or more. Meanwhile, billion-dollar-plus funding rounds continue at a steady pace, no longer treated as unusual.
Whether that holds up is anyone's guess. What does seem to be settled, at least for now, is the assumption that this AI cycle will produce some enormous winners. The open question is simply which companies end up being them.
What This Means for Companies Raising Capital
You Don't Need Billion-Dollar Funding to Benefit
Here's what I'd point out to any company owner reading these numbers and feeling like the world of capital raising has nothing to do with them: you're right, and you're wrong.
You're right that you're not going to raise $65 billion, and you don't need to. Almost nobody does. The story above is really about a dozen or so companies. Everyone else, meaning the overwhelming majority of good, growing businesses, still needs to raise capital the old-fashioned way: by building a real plan, finding real investors, and executing.
Investor Appetite Still Creates Opportunities
You're wrong if you conclude that this kind of capital environment doesn't touch you at all. Investor appetite for growth stories, and for technology and AI in particular, has never been stronger. That appetite doesn't only show up in billion-dollar rounds. It shows up in how willing everyday investors are to consider a well-run Regulation A+ offering from a company they've never heard of, provided the story is told well, and the company is genuinely promoted to the right audience.
Why Regulation A+ Remains a Practical Funding Path
That's really the whole game for a company that isn't a unicorn: getting your offering in front of investors who are already primed to say yes to growth and technology, and doing it in a way that's cost-effective rather than something that eats your capital raise alive before you've raised a dollar. We spend our time doing exactly that, and we coordinate the auditors, securities attorneys, and marketing agencies a company needs to get it done right.
The billion-dollar rounds make the headlines. The Reg A+ offerings are how most companies actually get funded, and get funded well, in a market like this one.
Ready to Explore Your Capital Raise?
If you want help thinking through what a raise like that looks like for your company, send a note to [email protected], and we'll get you started.
Rod Turner
Rod Turner is the founder and CEO of Manhattan Street Capital, the #1 Growth Capital service for mature startups and mid-sized companies to raise capital using Regulation A+. Turner has played a key role in building successful companies, including Symantec/Norton (SYMC), Ashton Tate, MicroPort, Knowledge Adventure, and more. He is an experienced investor who has built a Venture Capital business (Irvine Ventures) and has made angel and mezzanine investments in companies such as Bloom, Amyris (AMRS), Ask Jeeves, and eASIC.
Manhattan Street Capital is not a law firm, valuation service, underwriter, broker-dealer, or Title III crowdfunding portal, and we do not engage in any activities requiring any such registration. We do not provide advice on investments. Manhattan Street Capital does not structure transactions. Do not interpret any advice from Manhattan Street Capital staff as a replacement for advice from service providers in these professions. When Rod Turner provides advice, it is based on his observations of what works and what does not from a marketing perspective in online offerings. Rod does not tell the audience what to do or how to do it. He advises the audience on what is most likely to be cost-effectively marketed online. The choices of all aspects of companies' offerings are made by the companies that make the offerings.
